Month: July 2025

Earnings Release: Thursday, July 31, 2025, Before Market OpensConference Call and Webcast: Thursday, July 31, 2025, at 8:30 a.m. ET MONACO, July 28, 2025 (GLOBE NEWSWIRE) — Costamare Inc. (NYSE:CMRE) (the “Company”), announced today that it will release its results for the second quarter ended June 30, 2025 before the market opens in New York on July 31, 2025. Conference Call Details: On Thursday, July 31, 2025 at 8:30 a.m. ET, Costamare’s management team will hold a conference call to discuss the financial results. Participants should dial into the call 10 minutes before the scheduled time using the following numbers: 1-844-887-9405 (from the US), 0808-238-9064 (from the UK) or +1-412-317-9258 (from outside the US). Please quote “Costamare”. A replay of the conference call will be available until August 7, 2025. The...

ANN ARBOR, Mich., July 28, 2025 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), a world leader in spider silk technology*, today announced the formal signing of a multi-year agreement with a government agency in Southeast Asia to support the scale-up of its recombinant spider silk production. This agreement is the result of many years of groundwork by Kraig Labs and marks a significant step in the Company’s ongoing efforts to commercialize next-generation biomaterials. Under the terms of the agreement, Kraig Labs will gain access to government-supported rearing facilities, technical personnel, and infrastructure critical to accelerating production and expanding operational capacity. “This milestone reflects many years of work by our senior management...

Infortar will organize a webinar for investors on 4 August 2025 at 12:00 (EET) in Estonian and at 14:00 (EET) in English to introduce the second quarter 2025 results. The webinar will be attended by the Chairman of the Board of Infortar Ain Hanschmidt, the Managing Director Martti Talgre and Investor Relations Manager Kadri Laanvee. The webinar will be hosted on the Microsoft Teams platform. Please note that to participate, no prior registration is required, and no reminder of the webinar will be sent. You can either participate by joining from your web browser or via Microsoft Teams application. When using a smart device to join the webinar, you first need to download the Microsoft Teams application from either Play Store or App Store. Please join the webinar via the following links: 4 August 2025 at 12:00 (EET) Estonian webinar 4 August...

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) — Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that it will report its second quarter 2025 financial results and provide a business update on Monday, August 4, 2025. In connection with the earnings release, Syndax’s management will host a conference call and live audio webcast at 4:30 p.m. ET on Monday, August 4, 2025. The live audio webcast and accompanying slides may be accessed through the Events & Presentations page in the Investors section of the Company’s website. Alternatively, the conference call may be accessed through the following: Conference ID: Syndax2Q25Domestic Dial-in Number: 800-590-8290International Dial-in Number: 240-690-8800Live webcast: https://sndx-2q25.open-exchange.net For...

MISSISSAUGA, Ontario, July 28, 2025 (GLOBE NEWSWIRE) — Next Hydrogen Solutions Inc. (TSXV: NXH, OTCQB: NXHSF) (“Next Hydrogen” or the “Company”) is pleased to announce the successful commencement of operation of its revolutionary electrolyzer for clean hydrogen fueling at a major distribution centre. This achievement signifies the inauguration of Ontario’s largest onsite clean hydrogen generation and fueling station, designed to produce up to 650 kg of hydrogen per day to support fuel cell forklifts. Next Hydrogen manufactured the electrolyzer with its innovative cell design architecture, engineered and built the balance of plant as well as integrated compressors and dispensers. The Company is currently overseeing system operations and will continue to do so until the fueling station is formally transitioned...

IRVINE, Calif., July 28, 2025 (GLOBE NEWSWIRE) — Mobix Labs Inc. (Nasdaq: MOBX), a trailblazer in advanced connectivity solutions, today announced it will participate in the upcoming 2025 Leidos Supplier Innovation & Technology Symposium, taking place Thursday, August 7, 2025, at the Gaylord National Resort & Convention Center in Washington, D.C. Mobix Labs’ wireless division, RaGE Systems, will be front and center at the event, spotlighting its latest innovations in RF and wireless technologies—including millimeter-wave (mmW) sensor development, radar systems, advanced communication and integrated circuit (IC) solutions. These technologies are engineered to meet the rigorous demands of high-reliability sectors such as wireless infrastructure, aerospace, military, medical, and secure communications. The Leidos Supplier...

$3 million private financing plus an additional $9 million of proceeds due to exercise of warrants, for gross proceeds of approximately $12.0 million TORONTO, Ontario and CAMBRIDGE, Massachusetts, July 28, 2025 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company committed to discovery and development of therapeutic antibodies targeting toxic misfolded proteins in neurodegenerative diseases, such as Alzhiemer’s disease (AD), amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD), today announced that it has entered into a purchase agreement (the “Purchase Agreement”) with existing institutional and accredited investors to issue and sell an aggregate of approximately $3.0 million of warrants (the “Warrants”). The Warrants were sold at a price of $0.1875 per share through a...

Based on the primary endpoint of Clinical Dementia Rating Sum of Boxes (CDR-SB), patients treated with neflamapimod showed 54% risk reduction in clinically significant worsening compared to control at Week 32 of treatment (p=0.0037). This risk reduction improved to 64% (p=0.0001) among patients who have minimal evidence of AD co-pathology (ptau181 < 2.2 pg/mL at screening) At week 32 of the Extension phase, patients treated with neflamapimod demonstrated a significant reduction from baseline in plasma levels of glial fibrillary acidic protein (GFAP) Conference call and webcast today at 8:00 AM ET today to discuss results BOSTON, July 28, 2025 (GLOBE NEWSWIRE) — CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today announced positive...

DEER PARK, Ill., July 28, 2025 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report second quarter 2025 financial results on Thursday, August 7, 2025. Management will host a conference call and live audio webcast to discuss the results at 4:30 p.m. ET (3:30 p.m. CT). Dial In:        (800) 715-9871 or (646) 307-1963; Conference ID: 5899895 Webcast:      Click Here In addition to taking live questions from participants on the conference call, management will be answering emailed questions from investors. Investors can email questions to: investorrelations@etonpharma.com. The live webcast can also be accessed on the Investors section of Eton’s website at...

CALGARY, Alberta, July 28, 2025 (GLOBE NEWSWIRE) — Computer Modelling Group Ltd. (“CMG” or the “Company”) (TSX: CMG) is pleased to announce the appointment of Vipin Khullar as Chief Financial Officer, effective today. This leadership addition marks a major step in CMG’s continued evolution, adding key expertise to support the execution of the company’s growth strategy. “I am excited to welcome Vipin to the team,” said CMG CEO Pramod Jain. “At a pivotal moment in our evolution, he brings an exceptional blend of strategic insight and operational depth along with a proven track record of success. As we continue to scale and pursue ambitious growth through acquisitions, his financial leadership will be critical in ensuring disciplined execution and long-term value creation. His reputation as a collaborative and forward-thinking leader...